Knight Cancer Institute

Research Output

Filter
Letter
2020

A simplified prognostic index for chronic lymphocytic leukemia treated with ibrutinib: Results from a multicenter retrospective cohort study

Gordon, M. J., Sitlinger, A., Salous, T., Alqahtani, H., Churnetski, M., Rivera, X., Wisniewski, P., Cohen, J., Patel, K., Shadman, M., Choi, M., Hill, B., Stephens, D., Persky, D., Brander, D. & Danilov, A. V., Feb 2020, In : Leukemia Research. 89, 106302.

Research output: Contribution to journalLetter

Comparison of industry payments in 2017 with annual salary in a cohort of academic oncologists

Gill, J., Haslam, A., Crain, T., Herrera-Perez, D. & Prasad, V., Jan 1 2020, (Accepted/In press) In : JAMA internal medicine.

Research output: Contribution to journalLetter

Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer

Prasad, V., Feb 27 2020, In : The New England journal of medicine. 382, 9, 1 p.

Research output: Contribution to journalLetter

FDA Acceptance of Surrogate End Points for Cancer Drug Approval: 1992-2019

Chen, E. Y., Haslam, A. & Prasad, V., Jan 1 2020, (Accepted/In press) In : JAMA internal medicine.

Research output: Contribution to journalLetter

Open Access

Oncology Drug Advisory Committee Recommendations and the US Food and Drug Administration's Actions

Haslam, A., Gill, J. & Prasad, V., Feb 2020, In : Mayo Clinic Proceedings. 95, 2, p. 424-426 3 p.

Research output: Contribution to journalLetter

Open Access

Statistical significance and clinical evidence – Authors' reply

Prasad, V. & Booth, C. M., Mar 2020, In : The Lancet Oncology. 21, 3, p. e119

Research output: Contribution to journalLetter

Open Access
2019

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. Reply

Schmid, P., Chui, S. Y. & Emens, L. A., Mar 7 2019, In : The New England journal of medicine. 380, 10, p. 987-988 2 p.

Research output: Contribution to journalLetter

9 Scopus citations

Biopsy-proven thrombotic microangiopathy without schistocytosis on peripheral blood smear: A cautionary tale

Murphree, C. R., Nguyen, N. N., Shatzel, J. J., Olson, S. R., Chung, P. D., Lockridge, J. B., Andeen, N. K. & DeLoughery, T. G., Jan 1 2019, In : American Journal of Hematology. 94, 9, p. E234-E237

Research output: Contribution to journalLetter

Open Access

Characteristics of Public Comments Submitted to State Health Technology Assessment Programs in Oregon and Washington

Ahn, R., Herrera-Perez, D. & Prasad, V., Jan 1 2019, (Accepted/In press) In : JAMA Internal Medicine.

Research output: Contribution to journalLetter

1 Scopus citations

Concerning survival signal for eltrombopag in MDS/AML

Tao, D. & Prasad, V., Jan 1 2019, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalLetter

Direct oral anticoagulants in gastrointestinal malignancies: Is the convenience worth the risk?

Thapa, N., Shatzel, J., Deloughery, T. G. & Olson, S. R., Jan 1 2019, In : Journal of Gastrointestinal Oncology. 10, 4, p. 807-809 3 p.

Research output: Contribution to journalLetter

Healthcare expenditures of older patients with AML are similar between HMA and intensive induction chemotherapy

Lachowiez, C., Kearney, M., Meyers, G., Maziarz, R. & Cook, R. J., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalLetter

Insights on mechanisms of clonal evolution in chronic neutrophilic leukemia on ruxolitinib therapy

Stoner, R. C., Press, R. D., Maxson, J. E., Tyner, J. W. & Dao, K. H. T., Jan 1 2019, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalLetter

Long-term stroke risk in meningioma patients treated with conventionally fractionated photon-based radiation therapy

McClelland, S., Mitin, T., Kubicky, C. D. & Jaboin, J., Jan 1 2019, In : Journal of Radiosurgery and SBRT. 6, 1, p. 77-79 3 p.

Research output: Contribution to journalLetter

RE: A Reappraisal of Sex-Specific Cancer Survival Trends among Adolescents and Young Adults in the United States

Siegel, S. E., Coccia, P. F., Barr, R., Hayes-Lattin, B. & Bleyer, A., Jun 1 2019, In : Journal of the National Cancer Institute. 111, 6, p. 633-634 2 p.

Research output: Contribution to journalLetter

Open Access
1 Scopus citations

Reply to a. Dalla volta et al

Aggarwal, R., Huang, J., Alumkal, J., Feng, F. Y., Zhang, L., Stuart, J. M. & Small, E. J., Feb 1 2019, In : Journal of Clinical Oncology. 37, 4, p. 351-352 2 p.

Research output: Contribution to journalLetter

Reply to C.J. Sweeney et al

Parikh, R. B. & Prasad, V., Jan 1 2019, In : Journal of Clinical Oncology. 37, 19, p. 1680-1681 2 p.

Research output: Contribution to journalLetter

Reply to n. Cerveira et al

Berman, E., Druker, B. J. & Burwick, R., Jan 1 2019, In : Journal of Clinical Oncology. 37, 1, 1 p.

Research output: Contribution to journalLetter

Reply to S. Sorscher

Innocenti, F., Ou, F. S., Qu, X., Zemla, T., Niedzwiecki, D., Tam, R., Mahajan, S., Goldberg, R. M., Bertagnolli, M. M., Blanke, C., Sanoff, H., Atkins, J., Polite, B., Venook, A. P., Lenz, H. J. & Kabbarah, O., Sep 1 2019, In : Journal of Clinical Oncology. 37, 25, p. 2291-2292 2 p.

Research output: Contribution to journalLetter

The Clinical Trials Portfolio for On-label and Off-label Studies of Eculizumab

Kim, M. S. & Prasad, V., Jan 1 2019, (Accepted/In press) In : JAMA Internal Medicine.

Research output: Contribution to journalLetter

The Reply

Mandrola, J., Cifu, A., Prasad, V. & Foy, A., Sep 2019, In : American Journal of Medicine. 132, 9, p. e719

Research output: Contribution to journalLetter

The surgical nature of radiation oncology should be better reflected in pre-residency training

McClelland, S., Brown, S. A., Ramirez-Fort, M. K., Jaboin, J. & Zellars, R. C., Sep 1 2019, In : Reports of Practical Oncology and Radiotherapy. 24, 5, p. 507-508 2 p.

Research output: Contribution to journalLetter

2018

Automated decision tree to evaluate genetic abnormalities when determining prognostic risk in acute myeloid leukemia

Watanabe-Smith, K., Druker, B., Tyner, J. & Edwards, D. K., Jul 31 2018, In : Haematologica. 103, 8, p. e351-e355

Research output: Contribution to journalLetter

Brentuximab vedotin for frontline Hodgkin lymphoma: How much will a successful trial cost patients and payers?

Shanbhag, S. & Prasad, V., Nov 1 2018, In : European Journal of Cancer. 104, p. 252-253 2 p.

Research output: Contribution to journalLetter

1 Scopus citations

Cost-effectiveness of nusinersen for spinal muscular atrophy: Reply

Prasad, V., Jul 1 2018, In : JAMA Pediatrics. 172, 7, p. 701-702 2 p.

Research output: Contribution to journalLetter

1 Scopus citations

Crossover is not associated with faster trial accrual

Chen, E. Y. & Prasad, V., Mar 1 2018, In : Annals of Oncology. 29, 3, p. 776-777 2 p.

Research output: Contribution to journalLetter

1 Scopus citations

Efficacy and toxicity of therapy immediately after treatment with nivolumab in relapsed multiple myeloma

Pianko, M. J., Funt, S. A., Page, D. B., Cattry, D., Scott, E., Ansell, S. M., Borrello, I. M., Gutierrez, M., Lendvai, N., Hassoun, H., Landgren, C. O. & Lesokhin, A. M., Jan 2 2018, In : Leukemia and Lymphoma. 59, 1, p. 221-224 4 p.

Research output: Contribution to journalLetter

5 Scopus citations

Inconsistent reporting of potential conflicts of interest

Prasad, V., Jul 24 2018, In : JAMA - Journal of the American Medical Association. 320, 4, 1 p.

Research output: Contribution to journalLetter

1 Scopus citations

Inconsistent Reporting of Potential Conflicts of Interest

Prasad, V., Oct 1 2018, In : JAMA oncology. 4, 10, 1 p.

Research output: Contribution to journalLetter

1 Scopus citations

Inconsistent Reporting of Potential Conflicts of Interest

Prasad, V., Sep 1 2018, In : JAMA Pediatrics. 172, 9, 1 p.

Research output: Contribution to journalLetter

Inconsistent Reporting of Potential Conflicts of Interest

Prasad, V., Oct 1 2018, In : JAMA Internal Medicine. 178, 10, p. 1424-1425 2 p.

Research output: Contribution to journalLetter

In Regard to Palmer et al

McClelland, S. & Jaboin, J., Jul 15 2018, In : International Journal of Radiation Oncology Biology Physics. 101, 4, p. 999-1000 2 p.

Research output: Contribution to journalLetter

2 Scopus citations

In Regard to Sura et al

McClelland, S. & Jaboin, J., Oct 1 2018, In : International Journal of Radiation Oncology Biology Physics. 102, 2, p. 468-469 2 p.

Research output: Contribution to journalLetter

1 Scopus citations

In reply

Mailankody, S. & Prasad, V., Apr 1 2018, In : JAMA oncology. 4, 4, p. 586-587 2 p.

Research output: Contribution to journalLetter

2 Scopus citations

In reply

Prasad, V., Kaestner, V. & Mailankody, S., Sep 1 2018, In : JAMA oncology. 4, 9, p. 1300-1301 2 p.

Research output: Contribution to journalLetter

1 Scopus citations

In reply

Prasad, V. & Mailankody, S., Apr 1 2018, In : JAMA Internal Medicine. 178, 4, p. 588-589 2 p.

Research output: Contribution to journalLetter

2 Scopus citations

Non-myeloablative allogeneic hematopoietic cell transplantation for relapsed or refractory waldenström macroglobulinemia: Evidence for a graft-versus-lymphoma effect

Maffini, E., Anderson, L. D., Sandmaier, B. M., Green, D. J., Storer, B. E., Niederwieser, D., Maziarz, R. T., Maloney, D. G. & Storb, R., Jun 3 2018, In : Haematologica. 103, 6, p. e252-e255

Research output: Contribution to journalLetter

Reply to D.M. Ross et al and V. Florou et al

Berman, E., Druker, B. J. & Burwick, R., Sep 1 2018, In : Journal of Clinical Oncology. 36, 25, p. 2660-2661 2 p.

Research output: Contribution to journalLetter

The Radiation Safety of 5G Wi-Fi: Reassuring or Russian Roulette?

McClelland, S. & Jaboin, J., Aug 1 2018, In : International Journal of Radiation Oncology Biology Physics. 101, 5, p. 1274-1275 2 p.

Research output: Contribution to journalLetter

Total costs of chimeric antigen receptor T-cell immunotherapy

Hernandez, I., Prasad, V. & Gellad, W. F., Jul 1 2018, In : JAMA oncology. 4, 7, p. 994-996 3 p.

Research output: Contribution to journalLetter

25 Scopus citations
2017

A further strategy to combat the high price of anticancer drugs

Prasad, V., De Jesús, K. & Mailankody, S., Oct 1 2017, In : Nature Reviews Clinical Oncology. 14, 10, 1 p.

Research output: Contribution to journalLetter

5 Scopus citations

A Model to Promote Clinicians' Understanding of the Continuum of Advance Care Planning

Izumi, S. & Fromme, E., Mar 1 2017, In : Journal of Palliative Medicine. 20, 3, p. 220-221 2 p.

Research output: Contribution to journalLetter

2 Scopus citations

A phase I dose-ranging study of bendamustine and rituximab in chronic lymphocytic leukemia patients with comorbidities

Danilov, A. V., Lewis, L. D., Lansigan, F., Roudaia, L., Findley, D. L., Jones, S. Y., Highhouse, B., Beaulieu, B. B. & Brown, J. R., Sep 2017, In : British Journal of Haematology. 178, 5, p. 820-823 4 p.

Research output: Contribution to journalLetter

3 Scopus citations

Clinically meaningful benefit: Real world use compared against the American and European guidelines

Dreicer, J. J., Mailankody, S., Fahkrejahani, F. & Prasad, V., Dec 1 2017, In : Blood Cancer Journal. 7, 12, 645.

Research output: Contribution to journalLetter

3 Scopus citations

Conflicts of interest in Twitter

Kaestner, V., Brown, A., Tao, D. & Prasad, V., Sep 1 2017, In : The Lancet Haematology. 4, 9, p. e408-e409

Research output: Contribution to journalLetter

4 Scopus citations

Dabigatran reversal with idarucizumab

Radecki, R. P. & DeLoughery, T. G., Oct 26 2017, In : New England Journal of Medicine. 377, 17, p. 1690-1691 2 p.

Research output: Contribution to journalLetter

1 Scopus citations

Double autophagy stimulation using chemotherapy and mTOR inhibition combined with hydroxychloroquine for autophagy modulation in patients with relapsed or refractory multiple myeloma

Scott, E., Maziarz, R., Spurgeon, S., Medvedova, E., Gajewski, J., Reasor-Heard, S., Park, B., Kratz, A., Thomas, G., Loriaux, M., Cascio, M., Podolak, J., Gordon, M., Botelho, J., Stadtmauer, E., Amaravadi, R. & Vogl, D. T., Jun 26 2017, In : Haematologica. 102, 7, p. e261-e265

Research output: Contribution to journalLetter

5 Scopus citations

Extended thromboprophylaxis with direct oral anticoagulants for medical patients: A systematic review and meta-analysis

Tao, D. L., Bien, J. Y., Deloughery, T. & Shatzel, J. J., Feb 2 2017, In : Blood. 129, 5, p. 653-655 3 p.

Research output: Contribution to journalLetter

9 Scopus citations